Carnosine, carnosinase and kidney diseases

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2012, Vol 66, Issue 0

Abstract

Carnosine (beta-alanyl-L-histidine) is an endogenously synthesized dipeptide which is present in different human tissues, including the kidney. Carnosine is hydrolyzed by the enzyme carnosinase. There are two carnosinase homologues: serum secreted carnosinase and non-specific cytosolic dipeptidase, encoded by the genes CNDP1 and CNDP2 respectively and located on chromosome 18q22.3. Carnosine functions as a radical oxygen species scavenger and as a natural angiotensin converting enzyme inhibitor. Carnosine inhibits advanced glycation end product formation and reduces the synthesis of matrix proteins such as fibronectin and collagen type VI of podocytes and mesangial cells. In experimental studies it was shown that carnosine reduces the level of proinflammatory and profibrotic cytokines. It is suggested that carnosine is a naturally occurring anti-aging substance in human organisms with a beneficial effect on the cardiovascular system. This paper reports the results of studies concerning carnosine’s role in kidney diseases, particularly in ischemia/reperfusion induced acute renal failure, diabetic nephropathy, gentamicin-induced nephrotoxicity and also in blood pressure regulation. The correlations between serum carnosine and serum carnosinase activity and polymorphism in the CNDP1 gene are analyzed. The role of CNDP1 gene polymorphism in the development of diabetic nephropathy and non-diabetic chronic kidney disease is discussed. Carnosine is engaged in different metabolic pathways. It has nephroprotective features. Further studies of carnosine metabolism and its biological properties, particularly those concerning the human organism, are required.

Authors and Affiliations

Katarzyna Kiliś-Pstrusińska

Keywords

Related Articles

Angiotensyna (1-7) – nowe ogniwo układu renina-angiotensyna-aldosteron (RAA)

Odkrycie nowego enzymu konwertującego angiotensynę (ACE2) i badania nad biologicznymi właściwościami aktywności angiotensyny (1-7) wskazują na dużą złożoność funkcjonowania układu renina-angiotensyna-aldosteron (RAA). W...

Fentanyl i jego pochodne jako grupa nowych substancji psychoaktywnych (dopalaczy)

Fentanyl jest lekiem znanym od wielu lat, ma szerokie zastosowanie w medycynie ratunkowej i anestezjologii. Ze względu na silne działanie, zyskał miano popularnego środka uzależniającego. W ostatnich latach również pocho...

IL-18 and IL-18 binding protein concentration in ovarian follicular fluid of women with “tubal factor” subjected to in vitro fertilization

Introduction: Composition of follicular fluid is also regarded to be linked to quality of oocytes, fertilization and quality of the embryo. The aim of this study was to investigate the concentration of IL-18 and IL18BP i...

Component-resolved diagnostics of food allergy – do we know more?

Component - resolved diagnostics (CRD) is the research method that allows to determine the concentrations of specific immunoglobulin E against a particular allergenic components. The paper discusses the importance of CRD...

Rola estrogenów w chorobie Parkinsona

Choroba Parkinsona (PD) jest przewlekle postępującą chorobą neurodegeneracyjną ośrodkowego układu nerwowego, o dużej częstości występowania, wyraźnie zwiększającej się wraz z wiekiem. Choroba ta w znacznym stopniu pogars...

Download PDF file
  • EP ID EP66678
  • DOI -
  • Views 148
  • Downloads 0

How To Cite

Katarzyna Kiliś-Pstrusińska (2012). Carnosine, carnosinase and kidney diseases. Advances in Hygiene and Experimental Medicine, 66(0), 215-223. https://europub.co.uk/articles/-A-66678